ArticleAdvances in therapy2026

Real-World Treatment Patterns for Patients with High-Risk Biochemically Recurrent Nonmetastatic Castration‑Sensitive Prostate Cancer.

Stephen J Freedland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.